surmount 3 tirzepatide clinical trials after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase trial Tirzepatide trial shows additional 21.1% – pubmed tirzepatide after intensive lifestyle

consider slower titration or dose reduction of allulose if symptomatic

Onizuka, K

By slowing down digestion, more gastrointestinal side effects can occur, including: Nausea Vomiting Diarrhea Constipation Bloating Indigestion Abdominal discomfort Sulfur burps (foul, rotten-egg-smelling burps) Acid reflux Why Side Effects Peak During Titration Medication can affect everyone differently, and so people may experience various side effects at different times while taking a drug, depending on their dosage and other factors

95% CI, 0.37-0.83)

The next-generation therapy combines semaglutide with cagrilintide, a long-acting analog of amylin, which is a pancreatic peptide that lowers blood glucose levels and slows down gastric emptying